Home » Topics » Regulatory

Regulatory
RSS

FDA approves Vosevi for re-treatment of chronic HCV infection

July 19, 2017

FDA approves Nerlynx as extended adjuvant therapy for early stage HER2-positive breast cancer

July 18, 2017

FDA approves Tremfya for moderate to severe plaque psoriasis

July 14, 2017

Korea first to approve Invossa-K cell and gene therapy for degenerative arthritis

July 13, 2017

FDA approves Endari for sickle cell disease

July 10, 2017

Amenalief approved in Japan to treat herpes zoster

July 5, 2017

Mitsubishi Tanabe Pharma obtains approval in Japan for Canalia combination tablets

July 4, 2017

European Commission approves Pfizer's inotuzumab ozogamicin

July 3, 2017

FDA approves Bevyxxa for hospital and extended-duration prophylaxis of VTE

June 26, 2017

FDA approves Baxdela for ABSSSI

June 20, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...